Search Login Register

rasagiline (Azilect) Summary

Description: TVP-1022 is the (S)-isomer and a cardioprotective agent; monoamine oxidase type-B inhibitor that is not metabolized to amphetamine derivatives; can lead to fatal hypertensive crisis in patients who consume tyramine-rich foods

Also Known As: Azilect; 2,3-dihydro-N-2-propynyl-1H-inden-1-amine-(1R)-hydrochloride; AGN 1135; AGN-1135; N-2-propynyl-1-indanamine Show All >>

Networked: 243 relevant articles (41 outcomes, 79 trials/studies) for this Drug

Key Diseases for which rasagiline is Relevant

  1. Parkinson Disease (Parkinson's Disease) : 29 outcomes 62 studies in 170 results
  2. Fatigue : 2 outcomes 1 study in 5 results
  3. Hypokinesia (Bradykinesia) : 2 outcomes 1 study in 4 results
  4. Starvation : 2 outcomes 1 study in 2 results
  5. Dyskinesias (Dyskinesia) : 2 outcomes in 7 results
Show All >>

Drugs Related to rasagiline

  1. Levodopa (L Dopa)
  2. Monoamine Oxidase (MAO)
  3. Selegiline (E250)
  4. propargylamine
  5. Doxorubicin (Adriamycin)
  6. Mesylates (Mesylate)
  7. pramipexol (pramipexole)
  8. entacapone (Comtan)
  9. Rotenone
  10. Methylphenidate (Ritalin)
Show All >>

Therapies Related to rasagiline

  1. Activities of Daily Living (ADL)
  2. Drug Therapy (Chemotherapy)
  3. Transdermal Patch
  4. Deep Brain Stimulation
  5. Polypharmacy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.